LOC283999 Inhibitors
LOC283999 inhibitors Staurosporine and Bortezomib act on kinase activity and proteasome function, respectively, potentially affecting the phosphorylation state or stability of LOC283999. Inhibitors like U0126, LY294002, and PD98059 target key components of the MAPK and PI3K/AKT pathways, known to regulate a wide array of cellular functions, including those associated with LOC283999 if it is entwined with these pathways.
Compounds such as Cyclopamine and Rapamycin target the Hedgehog and mTOR pathways, respectively, which play crucial roles in cell signaling and growth. Their inhibition might alter the regulation of LOC283999, especially if it plays a role in these pathways. GW4869 and 2-Deoxy-D-glucose affect sphingolipid metabolism and glycolysis, and could thus influence LOC283999 by altering the cell's metabolic state. Tunicamycin's action on glycosylation can affect protein folding and trafficking, which may be crucial for the proper function of LOC283999 if it is a glycoprotein. Lastly, inhibitors such as WZ4003 and SP600125 act on NUAK kinases and JNK, which could intersect with the activity of LOC283999 through LKB1-mediated pathways and stress response signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A non-selective kinase inhibitor that can inhibit a broad range of kinases potentially upstream of LOC283999. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can disrupt the PI3K/AKT pathway, which may regulate LOC283999 activity or stability. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can prevent the degradation of proteins, potentially increasing LOC283999 levels. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
A Smoothened antagonist that can inhibit the Hedgehog signaling pathway, possibly affecting LOC283999 if related to this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can suppress mTORC1 signaling, possibly influencing LOC283999 if it is involved in mTOR signaling. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
A neutral sphingomyelinase inhibitor that can impact sphingolipid metabolism, potentially affecting LOC283999-related pathways. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glycolysis inhibitor that can alter energy metabolism, potentially affecting LOC283999 if it is energy-sensitive. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
An N-linked glycosylation inhibitor that can disrupt protein folding, potentially affecting glycosylated forms of LOC283999. | ||||||
WZ8040 | 1214265-57-2 | sc-364656 sc-364656A | 5 mg 10 mg | $255.00 $480.00 | ||
A NUAK1/2 inhibitor that can inhibit LKB1-mediated pathways, which may intersect with LOC283999 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can modulate the JNK signaling pathway, potentially influencing LOC283999 if it is JNK-regulated. | ||||||